This article is more than 6 month old.

PharmEasy to file for IPO next week 

Mini

API Holdings, the parent company of the online pharmacy retailer PharmEasy is expected to file IPO papers with SEBI next week, sources told CNBC-TV18.

PharmEasy to file for IPO next week 
API Holdings, the parent company of the online pharmacy retailer PharmEasy, is expected to file draft red herring prospectus with the markets regulator Securities Exchange Board of India (SEBI) next week, sources told CNBC-TV18.
The issue size for the public offering has been pegged between Rs 6,000 crore and Rs 6,500 crore. The issuance is expected to be an offer for sale with API Holdings setting the price band for the IPO at a discount of 15-20 percent in order to get good demand for the issue. The final valuation will depend on the demand seen around the listing, sources said.
API Holdings is looking to list by January-February 2022, depending on the relevant regulatory approval. The company is currently looking at a valuation of around $7 billion for the IPO.

It had managed to raise funding of $350 million back in April, led by Prosus Ventures and TPG Growth. Existing investors including Temasek, CDPQ, LGT Lightrock, Eight Roads, and Think Investments also participated in the series E round. With the round of investments the company officially became a unicorn.

API Holdings also has a majority stake in Thyrocare. The company had announced in June that it had acquired a 66.1 percent stake in Thyrocare from Dr A Velumani and affiliates at a price of Rs 1,300 per share aggregating to Rs 4,546 crore.

next story

Market Movers

Currency

CompanyPriceChng%Chng